Respiratory Tract Infection: A Focus on Upper Respiratory Tract Infection

Authors

  • Lomati Venkata Pavan Kumar Reddy
  • Chirlu Venkata Raja Department of Pharm-D, P. Rami Reddy Memorial College of Pharmacy, Kadapa-516003, India

DOI:

https://doi.org/10.37591/rrjom.v4i1.1460

Abstract

 

Respiratory tract infection (RTI) is considered as one of the most important public health problems in developing countries. Respiratory infections that occur in upper respiratory tract are seen with great frequency in both children and adults. RTIs are common cold, sore throat, sinusitis, laryngitis, pharyngitis, earache, and otitis media. Upper respiratory tract infections (URTIs) are general illnesses that are often treated with antibiotics even though bacteria cause only 25% of cases. Transmission of organisms causing URTIs occurs by droplet, aerosol, or direct hand-to-hand contact with infected secretions, with consequent passage to the eyes or nose. Patients with acute sinusitis experience symptoms for more than 1 to 2 weeks after a common cold, including extreme purulent nasal discharge, maxillary toothache, headache, and joint facial pain. Staphylococcus aureus has revealed a disconcerting propensity to develop resistance to antimicrobial agents and has become an important dispute for the clinicians. Improper prescribing of antibiotics for URTIs is a leading cause of antibiotic resistance in common community-acquired pathogens such as Streptococcus pneumoniae. Knowledge of the prevalent organisms and their current sensitivity is of great help in choosing an antibacterial.

 

Keywords: Morbidity and mortality, respiratory tract infection, sensitivity, upper respiratory tract infections

 

Downloads

Published

2019-04-18

Issue

Vol. 4 No. 1 (2014)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.